Surface Protein gp 120 Market
Global Surface Protein GP 120 Market Size, Share & Trends Report by Type (DS-003, BMD-104, HNG-156, M-48U1, and Others) and by Application (Hospitals and Clinics) Forecast (2022-2028)
The global surface protein gp 120 market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). Surface proteins are proteins that are found on a layer of cell membranes of more complex organisms. The rise in the prevalence of HIV is anticipated to accelerate the growth of the market. For instance, according to the data published by World Health Organization (WHO) in 2021, HIV is a global public health issue that claimed 36.3 million lives. Further, according to the same source, around 37.7 million were living with HIV at the end of 2020, out of which one-third of the people belong to the African region. Moreover, in 2020, 6,80,000 died from HIV-related causes and 1.5 million people acquired HIV. Thus, owing to this factor, the global surface protein gp 120 market is anticipated to grow in the forthcoming years.
Impact of COVID-19 Pandemic on Global Surface Protein GP 120 Market
The COVID-19 pandemic has resulted in a significant impact on the global surface GP protein 120 market. The COVID-19 pandemic has resulted in adverse disruption of the supply chain owing to the restrictions and lockdowns that led to delayed business deals. Moreover, the COVID-19 pandemic has disrupted the import and export of healthcare products globally. The non-invasive procedures were postponed to reallocate the resources to treat the COVID-19 patients. The unwillingness of people to visit healthcare facilities owing to the fear of getting infected has resulted in a significant decline in the growth of the global surface protein gp 120 market.
Segmental Outlook
The market is segmented based on type and application. Based on the type, the market is further sub-segmented into DS-003, BMD-104, HNG-156, M-48U1, and Others. Based on the application, the market is further sub-segmented into hospitals and clinics. Among these, the BMD-104 is anticipated to hold a considerable share in the market over the forecast period owing to its neuroprotective and antiviral functions.
Surface Protein GP 120 Market by Application, 2021 (%)
Clinics Segment is Anticipated to Hold a Prominent Share in the Global Surface Protein GP 120 Market
The clinics' segment is anticipated to hold a prominent share in the global surface protein GP 120 market since there are not any dedicated hospitals for HIV treatment. For instance, as per the HIV estimate report (2019) by Government, India had around 23.4 lakh people living with HIV in 2019. Moreover, in July 2020 under The National AIDS control program (NACP) of the government, there are more than 570 anti-retroviral treatment (ART) centers and 1264 link anti-retroviral treatment centers (ART). Thus, the rise in the number of clinics is anticipated to accelerate the growth of clinics, further driving the global surface protein gp 120 market.
Regional Outlook
The global surface protein gp 120 market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Asia-Pacific is anticipated to hold a considerable share owing to the rise in the prevalence of HIV infection in the region followed by the rise in government initiatives.
Global Surface Protein GP 120 Market, by Region 2022-2028
North America Region is Anticipated to Hold a prominent share in the global Surface Protein GP 120 market
North America is anticipated to hold a prominent share in the global surface protein GP market owing to the rise in government initiatives. For instance, the US Department of Health and Human Services' “Ending the HIV Epidemic in the US”(EHE) initiative aims to reduce the HIV infections in the US at 90% by 2030 to reduce new HIV infections to less than 3000 annually. Moreover, in February 2020, the Health and Human Services (HHS) has awarded $117 million to end the HIV epidemic in the U.S, out of which around $60 million is dedicated to linking, people with HIV who are newly diagnosed. Furthermore, in March 2021, Health Resource and Service Administration (HRSA) has awarded $99 million to expand access to HIV care, treatment, and support services under the EHE scheme. Thus, such initiatives are anticipated to accelerate the growth of the surface protein gp 120 market during the forecast period.
Market Players Outlook
The major companies serving the global surface protein gp 120 market include GlaxoSmithKline Plc, Sanofi SA, 3M, and more among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2020, GlaxoSmithKline Plc announced the approval of Rukobia from the US Food and Drug Administration (FDA). Rukobia is used to treat patients resistant to multiple HIV drugs with the help of gp protein on the surface of HIV while blocking the virus from entering the immune cells.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global surface protein gp 120 market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on The Global Surface Protein gp 120 Market
- Recovery Scenario of The Global Surface Protein gp 120 Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Bristol-Myers Squibb Co.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Boehringer Ingelheim International GmbH
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Gilead Sciences, Inc.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. GlaxoSmithKline Plc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. ViiV Healthcare
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Surface Protein gp 120 Market by Type
4.1.1. DS-003
4.1.2. BMD-104
4.1.3. HNG-156
4.1.4. M-48U1
4.2. Global Surface Protein gp 120 Market by Application
4.2.1. Hospital
4.2.2. Clinics
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. AbbVie Inc.
6.2. Arena Pharmaceuticals, Inc
6.3. AbbVie Inc.
6.4. Acceleron Pharma, Inc.
6.5. ACROBiosystems
6.6. Eli Lilly &Co.
6.7. Genentech, Inc. (F. Hoffmann-La Roche AG)
6.8. Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
6.9. Novartis AG
6.10. Mylan N.V
1. GLOBAL SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL DS-003 SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL BMD-104 IN SURFACE PROTEIN GP MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL HNG-156 IN SURFACE PROTEIN GP MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL M-48U1 IN SURFACE PROTEIN GP MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
7. GLOBAL HOSPITAL IN SURFACE PROTEIN GP MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL CLINICS IN SURFACE PROTEIN GP MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
10. NORTH AMERICAN SURFACE PROTEIN GP MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
11. NORTH AMERICAN SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
12. NORTH AMERICAN SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
13. EUROPEAN SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
14. EUROPEAN SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
15. EUROPEAN SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY TYPE 2021-2028 ($ MILLION)
18. ASIA-PACIFIC SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19. REST OF THE WORLD SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. REST OF THE WORLD SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
21. REST OF THE WORLD SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL SURFACE PROTEIN GP 120 MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL SURFACE PROTEIN GP 120 MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL SURFACE PROTEIN GP MARKET, 2021-2028 (%)
4. GLOBAL SURFACE PROTEIN GP MARKET SHARE BY TYPE, 2021VS 2028 (%)
5. GLOBAL DS-003 IN SURFACE PROTEIN GP MARKET SHARE BY GEOGRAPHY, 2021VS 2028 (%)
6. GLOBAL BMD-104 IN SURFACE PROTEIN GP 120 MARKET SHARE BY GEOGRAPHY, 2021VS 2028 (%)
7. GLOBAL HNG-156 IN SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL M-48U1 IN SURFACE PROTEIN GP 120 MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL SURFACE PROTEIN GP MARKET SHARE BY APPLICATION, 2021VS 2028 (%)
10. GLOBAL HOSPITAL IN SURFACE PROTEIN GP MARKET SHARE BY GEOGRAPHY, 2021VS 2028 (%)
11. GLOBAL CLINICS IN SURFACE PROTEIN GP MARKET SHARE BY GEOGRAPHY, 2021VS 2028 (%)
12. US SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
13. CANADA SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
14. UK SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
15. FRANCE SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
16. GERMANY SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
17. ITALY SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
18. SPAIN SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
19. REST OF EUROPE SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
20. INDIA SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
21. CHINA SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
22. JAPAN SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
23. SOUTH KOREA SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
24. REST OF ASIA-PACIFIC SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF THE WORLD SURFACE PROTEIN GP 120 MARKET SIZE, 2021-2028 ($ MILLION)
